Home | | | Search | | | Browse | | | Resources | | | Help | | | What's New | | | About |
---|
A 2-Year Study of an Investigational Drug in Obese Patients
This study is no longer recruiting patients.
Sponsored by: | Merck |
---|---|
Information provided by: | Merck |
Purpose
This is a 2-year study to assess the safety, tolerability, and efficacy of an investigational drug in obese patients.
MedlinePlus related topics: Obesity
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
Exclusion Criteria:
More Information
U.S. National Library of Medicine, Contact NLM Customer Service | ||||||||||||||
National Institutes of Health, Department of Health & Human Services | ||||||||||||||
Copyright, Privacy, Accessibility, Freedom of Information Act |